SGLT2 Inhibitors Benefit Adults 80+ with Chronic Kidney Disease
Medical Xpress1 min read35 words
A study presented at Kidney Week, the American Society of Nephrology’s annual meeting in Denver from Oct. 21‑25, found that SGLT2 inhibitors provide significant benefits for adults aged 80 and older with chronic kidney disease.
Read the original at Medical Xpress
🤖 AI-generated content - This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.